Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[What to do when faced with hyperprolactinemia?]

F Kuntschen1

  • 1FMH en endocrinologie, Monthey.

Praxis
|January 24, 1995
PubMed
Summary

Hyperprolactinemia, a common hormonal disorder affecting both sexes, requires extended treatment. Causes include medications, pituitary tumors, dopamine issues, and thyroid problems, with bromocriptine often effective.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Insulin therapy today and tomorrow].

Revue medicale de la Suisse romande·1995
Same author

[Interactive attention between practitioner and specialist].

Praxis·1995
Same author

[Current technologies and strategies in the treatment of insulin-dependent diabetes mellitus].

Schweizerische medizinische Wochenschrift. Supplementum·1994
Same author

[Hypercalcemia in Addison's disease caused by bilateral adrenal hemorrhage].

Schweizerische medizinische Wochenschrift·1986
Same author

Sulfonylureas in insulin-dependent (type I) diabetes: evidence for an extrapancreatic effect in vivo.

The Journal of clinical endocrinology and metabolism·1985
Same author

Insulin resistance in Type 1 (insulin-dependent) diabetes: dependence on plasma insulin concentration.

Diabetologia·1984

Area of Science:

  • Endocrinology
  • Reproductive Medicine

Context:

  • Hyperprolactinemia is a prevalent endocrine disorder with diverse clinical manifestations across age groups.
  • It affects both women and men, necessitating long-term management strategies.
  • Common etiologies include adverse drug reactions, prolactin-secreting pituitary adenomas (prolactinomas), dopamine dysregulation, and hypothyroidism.

Purpose:

  • To outline the clinical significance, diagnostic evaluation, and therapeutic approaches for hyperprolactinemia.
  • To discuss the management of prolactinomas based on tumor characteristics.
  • To highlight the implications for fertility and pregnancy following treatment.

Summary:

  • Hyperprolactinemia presents with varied clinical syndromes, influenced by patient age.
  • Diagnostic workup involves hormonal assays (prolactin, T4, TSH) and radiological imaging (CT/MRI).
  • Treatment options, including bromocriptine for prolactinomas, aim to normalize prolactin levels and restore fertility.

Impact:

  • Provides a comprehensive overview for clinicians managing hyperprolactinemia.
  • Clarifies diagnostic pathways and treatment selection for prolactinomas.
  • Offers guidance on reproductive outcomes after successful hyperprolactinemia management.

Related Experiment Videos